+919359902383

General Medicines by Linaclotide 145 mcg

Linaclotide 145 mcg Capsule

In stock

Description

Linaclotide 145 mcg Capsules for International Pharmaceutical Procurement

Linaclotide 145 mcg is an oral prescription medicine developed for the management of selected constipation-related gastrointestinal conditions. It acts locally in the intestine, where it increases intestinal fluid and supports easier passage of stool. The product shown is supplied under the Colozo brand in a bottle containing 10 capsules. Its approved indication, dosage, and patient eligibility may differ between countries, so procurement and use must follow the destination market’s regulations and approved product information.

Product Specifications

Generic Name: Linaclotide

Active Ingredient: Linaclotide

Composition: Each capsule contains Linaclotide 145 mcg.

Strength: 145 mcg per capsule

Dosage Form: Oral capsule

Pharmacological Class: Guanylate cyclase-C agonist

Therapeutic Category: Gastrointestinal medicine

Primary Treatment Area: Chronic idiopathic constipation

Route of Administration: Oral

About Linaclotide 145 mcg

Linaclotide is a peptide-based medicine that works primarily within the gastrointestinal tract. It belongs to a group of medicines known as guanylate cyclase-C agonists.

After oral administration, linaclotide binds to guanylate cyclase-C receptors on the intestinal lining. This action increases cyclic guanosine monophosphate and promotes the movement of chloride and bicarbonate into the intestine. Water follows these electrolytes, increasing intestinal fluid and helping stool pass through the bowel more comfortably.

Potential Treatment Benefits

For an appropriately selected patient, Linaclotide 145 mcg may help:

- Increase fluid within the intestine

- Improve stool consistency

- Support more regular bowel movements

- Reduce straining during defecation

- Improve selected symptoms associated with chronic constipation

Recommended Administration:

Linaclotide is generally taken once daily on an empty stomach, at least 30 minutes before a meal. However, the prescribed strength and schedule must follow the approved product label and medical advice applicable in the patient’s country.

Pregnancy, Breastfeeding, and Other Medicines:

Patients who are pregnant, planning a pregnancy, or breastfeeding should consult a healthcare professional before using linaclotide.

The prescriber should also be informed about other medicines being taken, especially:

- Other laxatives

- Stool-softening medicines

- Medicines that can cause diarrhea

- Products that may affect fluid or electrolyte balance

Frequently Asked Questions

1. What is the composition of this product?

Each capsule contains Linaclotide 145 mcg as its active pharmaceutical ingredient.

2. What is Linaclotide 145 mcg used for?

It is primarily prescribed for chronic idiopathic constipation in appropriate patients. Other authorized uses may vary according to the destination country’s approved label.

3. How does Linaclotide work?

Linaclotide is an agonist of the intestinal guanylate cyclase-C receptor (GCC). This helps transport fluid into the intestines and makes it easier for stool to pass through the gut.

4. Is Linaclotide 145 mcg a tablet or capsule?

It is an oral capsule, not a tablet. Website headings, descriptions, and quotation documents should identify it correctly as a capsule.

5. What is the pack size of Colozo 145 mcg?

The product shown in the supplied image contains 10 capsules per bottle. Current pack availability should be reconfirmed before ordering.

6. Can Linaclotide be used for intestinal obstruction?

No. It is contraindicated in patients with a known or suspected mechanical gastrointestinal obstruction.

7. What is the most common side effect?

Diarrhoea is the most frequently reported side effect. Severe or persistent diarrhea requires medical attention because it can cause dehydration.

8. Can this medicine be supplied internationally?

International supply depends on stock, prescription requirements, import permissions, product registration, and the pharmaceutical regulations of the destination country. Linaclotide chronic constipation medicine

Keywords